Hutch News

Hutch News

Stories tagged 'herpes'

When scientific hypotheses don’t pan out

Research studies are often built around an educated guess. What happens when those guesses are wrong?

Feb. 16, 2018 | By Rachel Tompa / Fred Hutch News Service

Researchers are always prepared for the possibility of a disproven hypothesis. But what happens when a beloved idea or dogma is shattered is less technical, less predictable. More human.

View story >


Stealing a secret from an unwelcome virus

An unexpected discovery in a herpes lab might bring relief to cancer patients

June 29, 2017 | By Sabin Russell / Fred Hutch News Service

Drs. Jia Zhu and Tao Peng made a unexpected discovery while searching for a treatment for herpes: The virus prompts skin cells to make a protein that keeps sensory nerves healthy, and might lead to a treatment for peripheral neuropathy, a side effect of chemotherapy.

View story >


Experimental herpes drug more effective than standard treatment

Pritelivir reduces viral shedding and lesions better than valacyclovir, study shows

Dec. 20, 2016 | By Mary Engel / Fred Hutch News Service

The results of the phase 2, randomized, double-blind trial published today in JAMA showed that when people with genital herpes took a daily oral dose of pritelivir, they reduced their rate of viral shedding by half compared to when they took valacyclovir. They also had fewer genital sores and less pain.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.